Search Results 1941-1950 of 16388 for dermatitis atópica

1. Clinical Trials - Mayo Clinic Children's Center

   ... eczema, urticaria, systemic anaphylaxis, and mast cell disorders, as well as POTS (postural orthostatic tachycardia syndrome). Comparisons of these values ...

2. A Study to Evaluate Ramucirumab Plus Trifluridine/Tipiracil to Treat Patients with Previously-treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma - Mayo Clinic

   EXCEPTIONS: Non-melanotic skin cancer or carcinoma-in-situ of the cervix. NOTE: If there is a history of prior malignancy, they must not be receiving other ...

3. A Study of the Safety and Effectiveness of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution for Non-Infectious Anterior Uveitis - Mayo Clinic

   Has open wounds/skin disease on the forehead area where the iontophoresis return electrode will be applied; Has severe lesions of the eyelids or the ocular ...

4. A Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Unilateral Head and Neck Cancer - Mayo Clinic

   - Age greater than or equal to 18. - Histopathologically confirmed diagnosis of one the following cancer types: - Salivary gland cancer - Skin cancer - Melanoma

5. How fit are you? See how you measure up - Mayo Clinic

   See also. Balance exercises · Blood Doping · Can I exercise if I have atopic dermatitis? Core exercises · Exercise benefits · Exercise and chronic disease ...

6. Overview - Translational Neuroimmunology Laboratory - Mayo Clinic Research

   An anti-axonal cytotoxic T cell (turquoise) attacks immunologically stressed axons (purple). Evidence from the Translational Neuroimmunology Lab indicates ...

7. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

   Subjects with any malignancy that requires treatment during the study period, that has required treatment within 1 year of screening (including excision of skin ...

8. A Study to Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

   History of malignancy < 5 years prior to signing the informed consent, except for adequately treated basal cell or squamous cell skin cancer or in situ cervical ...

9. Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis - Mayo Clinic

   Other malignancy within last 3 years other than certain limited skin, cervical, prostate, breast, or bladder cancers; Other ongoing, uncontrolled illnesses ...

10. A Study of PRN1008 in Patients With Pemphigus - Mayo Clinic

    A history of malignancy of any type, other than surgically excised non-melanoma skin cancers or in situ cervical cancer within 5 years before Day 1. Use of ...